Evidence map›Paper›PMID 31297120›Full record

ArticleFrontiers in immunology2019

Chun-Lian Tang, Xiao-Hong Yu, Yan Li, Rong-Hui Zhang, Jun Xie, Zhi-Ming Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Glycogen Hydrogel Loaded withBiomolecules · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. DoesCells · 2021
    Review
  17. Review
  18. Mining Helminths for Novel Therapeutics.Trends in molecular medicine · 2021
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chun-Lian TangWuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Xiao-Hong YuWuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Yan LiWuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Rong-Hui ZhangWuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Jun XieMedical College of Wuhan University of Science and Technology, Wuhan, China.
Zhi-Ming LiuWuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Wuhan University of Science and Technology · CNWuchang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes is a metabolic disorder characterized by persistently elevated glucose levels. There is no effective treatment strategy for this condition, and it poses a massive economic burden globally.

Indexed as

Antigens, HelminthAnimalsCytokinesDiabetes Mellitus, Type 2MiceOvumSchistosoma japonicumTh2 CellsT-Lymphocytes, RegulatoryAntigens, HelminthCytokinescytokinesLeprdb/db miceregulatory T cellsSchistosoma japonicum soluble egg antigentype 2 diabetes

Identifiers

PMID31297120
PMCPMC6607994
OpenAlexW2952181019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.